Stock Information

• Organogenesis Holdings shares are trading lower after the company reported Q4 financial results and issued FY26 sales guidance below estimates. Also, BTIG lowered its price target on the stock from $9 to $8.
  Fri, Feb 27, 2026 11:50 AM
• Organogenesis Holdings Reports Q4 2025 Results: Full Earnings Call Transcript
  Fri, Feb 27, 2026 11:00 AM
• BTIG Maintains Buy on Organogenesis Holdings, Lowers Price Target to $8
  Fri, Feb 27, 2026 6:35 AM
• Organogenesis Holdings Inc (NASDAQ:ORGO) Soars on Stellar Q4 Earnings Beat
  Fri, Feb 27, 2026 12:21 AM
• Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript
  Thu, Feb 26, 2026 11:57 PM
• Organogenesis Holdings shares are trading lower after the company reported Q4 financial results and issued FY26 sales guidance below estimates.
  Thu, Feb 26, 2026 6:01 PM
• Organogenesis Holdings Sees FY2026 Sales $350.000M-$420.000M vs $543.400M Est.
  Thu, Feb 26, 2026 5:26 PM
• Organogenesis Holdings Q4 Earnings Report: What Investors Need to Know
  Thu, Feb 26, 2026 5:26 PM
• Organogenesis Hldgs Q4 Adj. EPS $0.40 Beats $0.21 Estimate, Sales $225.607M Beat $172.700M Estimate.
  Thu, Feb 26, 2026 5:25 PM
• Earnings Scheduled For February 26, 2026
  Thu, Feb 26, 2026 7:11 AM

Financial data not available